Anti-Human CD44 Therapeutic Antibody (huPTA-4621)

Recombinant monoclonal antibody to CD44. huPTA-4621 is a humanized antibody that can be potentially used in the treatment of head and neck squamous cell carcinoma (HNSCC).
Supplier Creative Biolabs
Product # TAB-236LC
Pricing Inquiry
Type Humanized antibody
Applications FuncS
Host Human
Target CD44 (cluster of differentiation 44)
Feedback